poisar

Stocks · News reference

VivoSim Labs Anticipates 500% Revenue Growth In FY27; Receives $5M Milestone Payment From Eli Lilly

BenzingaJul 15, 2026, 12:09 PMBenzinga Newsdesk

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 15, 2026, 12:09 PM
Checked
Jul 15, 2026, 12:09 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading